With the common treatment challenges of overcoming the resistance to DNA damaging therapies and given that NEDD9 expression can affect the sensitivity to UV irradiation and regulate ATM-related non-canonical EMT signaling, this protein merits further investigation as a potential biomarker for treatment response in an NSCLC setting. The gene discussed is ATM; the disease is non-small cell lung carcinoma.